In addition, the analyses in this study suggested some novel prognostic BC biomarkers: RASSF7 for luminal A, DCTPP1 for luminal B, DHRS11, KLC3, NAGS, and TMEM98 for HER2, and ABHD14A and ADSSL1 for basal. This evidence concerns the gene TMEM98 and breast cancer.